Related Experiment Video
Updated: Sep 15, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
COVID-19 Induced Cholangiopathy: A Case Report
Bassem Al Hariri1,2,3, Muhammad Sharif1,2, Lujain Al-Emadi1
1Hamad Medical Corporation, Doha, Qatar.
COVID-19 can cause serious liver injury, including a rare condition called COVID-19-induced cholangiopathy. This case highlights the importance of recognizing and managing this liver complication in patients with severe COVID-19.
Area of Science:
- Hepatology
- Infectious Diseases
- Gastroenterology
Background:
- COVID-19 primarily affects the respiratory system but can lead to multi-organ complications, including liver injury.
- Mechanisms of COVID-19 liver injury include direct viral effects, inflammation, hypoxia, and drug-induced liver injury (DILI).
- Post-COVID cholangiopathy is an emerging liver complication with potential autoimmune overlap.
Observation:
- A 60-year-old male with COVID-19 pneumonia developed elevated liver enzymes one week after admission.
- Initial suspicion of drug-induced liver injury (DILI) and treatment with ursodeoxycholic acid (UDCA) did not resolve the liver dysfunction.
- Magnetic resonance cholangiopancreatography revealed findings consistent with COVID-19-induced cholangiopathy.
Findings:
- COVID-19-induced cholangiopathy is characterized by periportal inflammation, intrahepatic biliary dilatation, and stricturing.
- Doubling the UDCA dosage led to gradual biochemical improvement in liver function tests.
- The patient was discharged against medical advice despite partial recovery.
Implications:
- COVID-19-induced cholangiopathy is a rare but significant liver complication requiring multidisciplinary management.
- Further research is necessary to understand the long-term hepatic sequelae of COVID-19.
- Early recognition and appropriate treatment strategies are crucial for managing COVID-19-related liver injury.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management

